Table 2.
Drug | Index † | Gene name | Slope ‡ | r § | P‐value | GenBank no. | Product |
---|---|---|---|---|---|---|---|
S‐1 | 202922_at | GCLC | 1.69 | 0.627 | <0.001 | BF676980 | Glutamate‐cysteine ligase, catalytic subunit |
207463_x_at | PRSS3 | 4.70 | 0.631 | <0.001 | NM_002771 | Mesotrypsin preproprotein | |
202609_at | EPS8 | 3.74 | 0.617 | <0.001 | NM_004447 | Epidermal growth factor receptor pathway substrate 8 | |
202831_at | GPX2 | 5.75 | 0.614 | <0.001 | NM_002083 | Gastrointestinal glutathione peroxidase 2 | |
218854_at | SART2 | −3.47 | −0.602 | <0.001 | NM_013352 | Squamous cell carcinoma antigen recognized by T cells 2 | |
203476_at | TPBG | −3.78 | −0.593 | 0.001 | NM_006670 | 5T4 oncofetal trophoblast glycoprotein | |
217794_at | DKFZp564J157 | 1.94 | 0.593 | 0.001 | NM_018457 | DKFZp564J157 protein isoform 1 | |
201425_at | ALDH2 | 3.64 | 0.586 | 0.001 | NM_000690 | Mitochondrial aldehyde dehydrogenase 2 precursor | |
208453_s_at | XPNPEP1 | 1.57 | 0.581 | 0.001 | NM_006523 | X‐prolyl aminopeptidase (aminopeptidase P) 1, soluble | |
205402_x_at | PRSS2 | 4.48 | 0.557 | 0.001 | NM_002770 | Protease, serine, 2 preproprotein | |
219115_s_at | IL20RA | 2.35 | 0.555 | 0.001 | NM_014432 | Interleukin 20 receptor, alpha | |
221016_s_at | TCF7L1 | −2.08 | −0.557 | 0.001 | NM_031283 | HMG‐box transcription factor TCF‐3 | |
202794_at | INPP1 | 1.83 | 0.552 | 0.002 | NM_002194 | Inositol polyphosphate‐1‐phosphatase | |
203832_at | SNRPF | 1.64 | 0.551 | 0.002 | NM_003095 | Small nuclear ribonucleoprotein polypeptide F | |
201829_at | NET1 | 1.71 | 0.545 | 0.002 | AW263232 | Neuroepithelial cell transforming gene 1 | |
204608_at | ASL | 1.86 | 0.546 | 0.002 | NM_000048 | Argininosuccinate lyase | |
220189_s_at | MGAT4B | 1.51 | 0.546 | 0.002 | NM_014275 | Mannosyl‐glycoprotein β‐1,4‐N‐acetylglucosaminyltransferase, isoenzyme B isoform 1 | |
209605_at | TST | 5.09 | 0.544 | 0.002 | D87292 | Rhodanese | |
211184_s_at | aie‐75 | 3.17 | 0.541 | 0.002 | AB006955 | AIE‐75 | |
202674_s_at | LMO7 | 1.97 | 0.540 | 0.002 | NM_005358 | LIM domain only 7 | |
UFT | 205395_s_at | MRE11A | −3.68 | −0.749 | <0.001 | NM_005590 | Meiotic recombination 11 homolog A isoform 2 |
201312_s_at | SH3BGRL | −5.76 | −0.639 | <0.001 | NM_003022 | SH3 domain binding glutamic acid‐rich protein like | |
203752_s_at | JUND | 1.50 | 0.633 | <0.001 | NM_005354 | Jun‐D proto‐oncogene | |
204333_s_at | AGA | −1.91 | −0.632 | <0.001 | NM_000027 | Aspartylglucosaminidase precursor | |
217788_s_at | GALNT2 | −2.21 | −0.616 | <0.001 | NM_004481 | Polypeptide N‐acetylgalactosaminyltransferase 2 | |
218854_at | SART2 | −4.22 | −0.620 | <0.001 | NM_013352 | Squamous cell carcinoma antigen recognized by T cells 2 | |
209526_s_at | HRP‐3 | −4.47 | −0.581 | 0.001 | AB029156 | HRP‐3 | |
214600_at | TEAD1 | −2.17 | −0.580 | 0.001 | AW771935 | TEA domain family member 1 | |
205187_at | Smad5 | −2.34 | −0.567 | 0.001 | AF010601 | SMAD5 | |
212983_at | HRAS | −2.05 | −0.564 | 0.001 | NM_005343 | v‐Ha‐ras Harvey rat sarcoma viral oncogene homolog isofrom 1 | |
217759_at | TRIM44 | −1.89 | −0.554 | 0.002 | NM_017583 | DIPB protein | |
201481_s_at | PYGB | 6.03 | 0.552 | 0.002 | NM_002862 | Brain glycogen phosphorylase | |
203874_s_at | SMARCA1 | −3.09 | −0.540 | 0.002 | NM_003069 | SWI/SNF‐related matrix‐associated actin‐dependent regulator of chromatin a1 isoform a | |
201177_s_at | UBA2 | −1.68 | −0.538 | 0.002 | NM_005499 | SUMO‐1 activating enzyme subunit 2 | |
201540_at | FHL1 | −4.53 | −0.530 | 0.003 | NM_001449 | Four and a half LIM domains 1 | |
202602_s_at | HTATSF1 | −1.67 | −0.530 | 0.003 | NM_014500 | HIV TAT specific factor 1 | |
200821_at | LAMP2 | −1.78 | −0.524 | 0.003 | NM_013995 | Lysosomal‐associated membrane protein 2 precursor | |
214257_s_at | SEC22L1 | −1.93 | −0.524 | 0.003 | AA890010 | Hypothetical protein | |
202082_s_at | SEC14L1 | −1.74 | −0.518 | 0.003 | AV748469 | SEC14 (S. cerevisiae)‐like 1 | |
203953_s_at | CLDN3 | 8.32 | 0.517 | 0.003 | BE791251 | Claudin 3 | |
5′‐DFUR | 201481_s_at | PYGB | 7.46 | 0.686 | <0.001 | NM_002862 | Brain glycogen phosphorylase |
203586_s_at | ARF4L | −1.97 | −0.669 | <0.001 | NM_001661 | ADP‐ribosylation factor 4‐like | |
205395_s_at | MRE11A | −3.30 | −0.674 | <0.001 | NM_005590 | Meiotic recombination 11 homolog A isoform 2 | |
202620_s_at | PLOD2 | −5.49 | −0.644 | <0.001 | NM_000935 | Procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 2 isoform b | |
214600_at | TEAD1 | −2.33 | −0.626 | <0.001 | AW771935 | TEA domain family member 1 | |
218854_at | SART2 | −4.30 | −0.634 | <0.001 | NM_013352 | Squamous cell carcinoma antigen recognized by T cells 2 | |
222065_s_at | FLII | −1.73 | −0.632 | <0.001 | AI830227 | Flightless I homolog (Drosophila) | |
204201_s_at | PTPN13 | −3.53 | −0.610 | <0.001 | NM_006264 | Protein tyrosine phosphatase, non‐receptor type 13 isoform 2 | |
204646_at | DPYD | −4.86 | −0.603 | <0.001 | NM_000110 | Dihydropyrimidine dehydrogenase | |
219255_x_at | IL17RB | 4.16 | 0.603 | <0.001 | NM_018725 | Interleukin 17B receptor isoform 1 precursor | |
210827_s_at | ESE‐1 | 3.79 | 0.599 | 0.001 | U73844 | ESE‐1a | |
200989_at | HIF1A | −1.61 | −0.592 | 0.001 | NM_001530 | Hypoxia‐inducible factor 1, α subunit isoform 1 | |
220147_s_at | C12orf14 | 1.69 | 0.592 | 0.001 | NM_021238 | Chromosome 12 open reading frame 14 | |
201528_at | RPA1 | −1.89 | −0.580 | 0.001 | BG398414 | Replication protein A1, 70 kDa | |
201540_at | FHL1 | −4.94 | −0.578 | 0.001 | NM_001449 | Four and a half LIM domains 1 | |
212983_at | HRAS | −2.09 | −0.577 | 0.001 | NM_005343 | v‐Ha‐ras Harvey rat sarcoma viral oncogene homolog isofrom 1 | |
219553_at | NME7 | −1.94 | −0.580 | 0.001 | NM_013330 | Nucleoside‐diphosphate kinase 7 isoform a | |
213330_s_at | STIP1 | −1.64 | −0.576 | 0.001 | BE886580 | Stress‐induced‐phosphoprotein 1 | |
201289_at | CYR61 | −5.85 | −0.572 | 0.001 | NM_001554 | Cysteine‐rich, angiogenic inducer, 61 | |
203953_s_at | CLDN3 | 9.18 | 0.572 | 0.001 | BE791251 | Claudin 3 | |
Capecitabine | 201481_s_at | PYGB | 7.79 | 0.742 | <0.001 | NM_002862 | Brain glycogen phosphorylase |
218059_at | LOC51123 | 1.71 | 0.660 | <0.001 | NM_016096 | HSPC038 protein | |
218854_at | SART2 | −4.56 | −0.696 | <0.001 | NM_013352 | Squamous cell carcinoma antigen recognized by T cells 2 | |
201528_at | RPA1 | −2.01 | −0.641 | <0.001 | BG398414 | Replication protein A1, 70 kDa | |
200989_at | HIF1A | −1.68 | −0.637 | <0.001 | NM_001530 | Hypoxia‐inducible factor 1, α subunit isoform 1 | |
203586_s_at | ARF4L | −1.80 | −0.632 | <0.001 | NM_001661 | ADP‐ribosylation factor 4‐like | |
204073_s_at | C11orf9 | 3.24 | 0.618 | <0.001 | NM_013279 | Chromosome 11 open reading frame 9 | |
205395_s_at | MRE11A | −2.93 | −0.620 | <0.001 | NM_005590 | Meiotic recombination 11 homolog A isoform 2 | |
204201_s_at | PTPN13 | −3.38 | −0.605 | <0.001 | NM_006264 | Protein tyrosine phosphatase, non‐receptor type 13 isoform 2 | |
209620_s_at | ABCB7 | −2.09 | −0.605 | <0.001 | AB005289 | ATP‐binding cassette, subfamily B (MDR/TAP), member 7 | |
222065_s_at | FLII | −1.60 | −0.606 | <0.001 | AI830227 | Flightless I homolog (Drosophila) | |
213330_s_at | STIP1 | −1.62 | −0.590 | 0.001 | BE886580 | Stress‐induced‐phosphoprotein 1 (Hsp70/Hsp90‐organizing protein) | |
214600_at | TEAD1 | −2.12 | −0.590 | 0.001 | AW771935 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | |
217848_s_at | PP | 1.96 | 0.592 | 0.001 | NM_021129 | Inorganic pyrophosphatase | |
32837_at | AGPAT2 | 1.96 | 0.589 | 0.001 | U56418 | Lysophosphatidic acid acyltransferase‐beta | |
204351_at | S100P | 8.87 | 0.581 | 0.001 | NM_005980 | S100 calcium binding protein P | |
205403_at | IL1R2 | 6.30 | 0.579 | 0.001 | NM_004633 | Interleukin 1 receptor, type II precursor | |
209160_at | c‐hluPGFS | 7.40 | 0.578 | 0.001 | AB018580 | HluPGFS | |
212983_at | HRAS | −2.02 | −0.578 | 0.001 | NM_005343 | v‐Ha‐ras Harvey rat sarcoma viral oncogene homolog isofrom 1 | |
36742_at | ZNFB7 | 2.67 | 0.577 | 0.001 | U34249 | Zinc finger protein | |
CDDP | 208012_x_at | SP110 | −2.77 | −0.662 | <0.001 | NM_004509 | SP110 nuclear body protein isoform a |
201278_at | DAB2 | −2.45 | −0.636 | <0.001 | N21202 | Disabled homolog 2, mitogen‐responsive phosphoprotein | |
218070_s_at | GMPPA | −1.66 | −0.593 | 0.001 | NM_013335 | GDP‐mannose pyrophosphorylase A | |
201661_s_at | ACSL3 | −1.51 | −0.592 | 0.001 | NM_004457 | Acyl‐CoA synthetase long‐chain family member 3 | |
203423_at | RBP1 | 4.07 | 0.584 | 0.001 | NM_002899 | Retinol binding protein 1, cellular | |
202659_at | PSMB10 | −3.07 | −0.581 | 0.001 | NM_002801 | Proteasome beta 10 subunit proprotein | |
211429_s_at | MYCPBP | −7.04 | −0.577 | 0.001 | AF119873 | PRO2275 | |
217844_at | CTDSP1 | −1.74 | −0.575 | 0.001 | NM_021198 | CTD (carboxy‐terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 | |
201482_at | QSCN6 | −3.49 | −0.569 | 0.001 | NM_002826 | quiescin Q6 isoform a | |
202100_at | RALB | −2.02 | −0.561 | 0.001 | BG169673 | v‐ral simian leukemia viral oncogene homolog B | |
203228_at | PAFAH1B3 | 1.92 | 0.558 | 0.001 | NM_002573 | Platelet‐activating factor acetylhydrolase, isoform Ib, gamma subunit 29 kDa | |
204306_s_at | CD151 | −1.94 | −0.556 | 0.001 | NM_004357 | CD151 antigen | |
209761_s_at | SP110 | −1.91 | −0.555 | 0.001 | AA969194 | SP110 nuclear body protein | |
203964_at | NMI | −2.38 | −0.544 | 0.002 | NM_004688 | N‐myc and STAT interactor | |
1729_at | TRADD | −1.68 | −0.533 | 0.002 | NM_003789 | Tumor necrosis factor receptor type 1 associated protein | |
202733_at | P4HA2 | −1.58 | −0.533 | 0.002 | NM_004199 | Procollagen‐proline, 2‐oxoglutarate 4‐dioxygenase,alpha polypeptide II | |
204001_at | SNAPC3 | 1.52 | 0.531 | 0.003 | NM_003084 | Small nuclear RNA activating complex, polypeptide 3,50 kDa | |
221523_s_at | RAGD | 2.92 | 0.519 | 0.003 | AL138717 | Ras‐related GTP binding D | |
201887_at | IL13RA1 | −2.13 | −0.515 | 0.004 | NM_001560 | Interleukin 13 receptor, alpha 1 precursor | |
202863_at | SP100 | −2.50 | −0.514 | 0.004 | NM_003113 | Nuclear antigen Sp100 | |
CPT11 | 202870_s_at | CDC20 | 2.08 | 0.694 | <0.001 | NM_001255 | Cell division cycle 20 |
203832_at | SNRPF | 2.26 | 0.657 | <0.001 | NM_003095 | Small nuclear ribonucleoprotein polypeptide F | |
205085_at | ORC1L | 1.64 | 0.751 | <0.001 | NM_004153 | Origin recognition complex, subunit 1 | |
205412_at | ACAT1 | 3.01 | 0.730 | <0.001 | NM_000019 | Acetyl‐coenzyme A acetyltransferase 1 precursor | |
206653_at | POLR3G | 2.60 | 0.664 | <0.001 | BF062139 | Polymerase (RNA) III (DNA directed) polypeptide G (32 kDa) | |
208967_s_at | adk2 | 1.60 | 0.723 | <0.001 | U39945 | Adenylate kinase 2 | |
210567_s_at | SKP2 | 2.13 | 0.661 | <0.001 | BC001441 | S‐phase kinase‐associated protein 2, isoform 2 | |
212136_at | ATP2B4 | −3.26 | −0.744 | <0.001 | AW517686 | ATPase, Ca++ transporting, plasma membrane 4 | |
214177_s_at | PBXIP1 | −1.68 | −0.714 | <0.001 | AI935162 | Pre‐B‐cell leukemia transcription factor interacting protein 1 | |
215127_s_at | RBMS1 | −2.43 | −0.663 | <0.001 | AL517946 | RNA binding motif, single stranded interacting protein 1 | |
217988_at | CCNB1IP1 | 2.50 | 0.680 | <0.001 | NM_021178 | Cyclin B1 interacting protein 1 isoform a | |
220892_s_at | PSAT1 | 3.14 | 0.697 | <0.001 | NM_021154 | Phosphoserine aminotransferase isoform 2 | |
204127_at | RFC3 | 1.62 | 0.640 | <0.001 | BC000149 | Replication factor C 3, isoform 1 | |
205909_at | POLE2 | 1.64 | 0.640 | <0.001 | NM_002692 | DNA polymerase epsilon subunit 2 | |
200078_s_at | ATP6V0B | 1.86 | 0.634 | <0.001 | BC005876 | ATPase, H+ transporting, lysosomal 21 kDa, V0 subunit c″ | |
202705_at | CCNB2 | 1.55 | 0.622 | <0.001 | NM_004701 | Cyclin B2 | |
204244_s_at | ASK | 1.80 | 0.624 | <0.001 | NM_006716 | Activator of S phase kinase | |
204559_s_at | LSM7 | 1.91 | 0.632 | <0.001 | NM_016199 | U6 snRNA‐associated Sm‐like protein LSm7 | |
206752_s_at | DFFB | 2.58 | 0.631 | <0.001 | NM_004402 | DNA fragmentation factor, 40 kDa, beta polypeptide isoform 1 | |
216321_s_at | NR3C1 | −6.46 | −0.624 | <0.001 | X03348 | β‐Glucocorticoid receptor | |
Paclitaxel | 201272_at | AKR1B1 | 3.88 | 0.581 | 0.001 | NM_001628 | Aldo‐keto reductase family 1, member B1 |
205659_at | HDAC9 | 3.14 | 0.577 | 0.001 | NM_014707 | Histone deacetylase 9 isoform 3 | |
204867_at | GCHFR | −2.41 | −0.566 | 0.001 | NM_005258 | GTP cyclohydrolase I feedback regulatory protein | |
206247_at | MICB | 2.72 | 0.532 | 0.003 | NM_005931 | MHC class I polypeptide‐related sequence B | |
204981_at | SLC22A18 | −2.99 | −0.530 | 0.003 | NM_002555 | Tumor suppressing subtransferable candidate 5 | |
201012_at | ANXA1 | 3.48 | 0.516 | 0.004 | NM_000700 | Annexin I | |
201564_s_at | FSCN1 | 3.95 | 0.517 | 0.004 | NM_003088 | Fascin 1 | |
207717_s_at | PKP2 | −2.32 | −0.515 | 0.004 | NM_004572 | Plakophilin 2 isoform 2b | |
210264_at | GPR35 | −1.98 | −0.515 | 0.004 | AF089087 | G protein‐coupled receptor | |
202722_s_at | GFPT1 | −1.75 | −0.514 | 0.004 | NM_002056 | Glucosamine‐fructose‐6‐phosphate aminotransferase | |
205443_at | SNAPC1 | 1.79 | 0.512 | 0.004 | NM_003082 | Small nuclear RNA activating complex, polypeptide 1, 43 kDa | |
201746_at | TP53 | −1.67 | −0.506 | 0.004 | NM_000546 | Tumor protein p53 | |
204527_at | MYO5A | 1.97 | 0.504 | 0.005 | NM_000259 | Myosin VA (heavy polypeptide 12, myoxin) | |
201540_at | FHL1 | 3.43 | 0.503 | 0.005 | NM_001449 | Four and a half LIM domains 1 | |
203423_at | RBP1 | 2.66 | 0.498 | 0.005 | NM_002899 | Retinol binding protein 1, cellular | |
204404_at | SLC12A2 | −2.63 | −0.497 | 0.005 | NM_001046 | Solute carrier family 12, member 2 | |
213757_at | EIF5A | 2.92 | 0.492 | 0.006 | AA393940 | Eukaryotic translation initiation factor 5 A | |
209016_s_at | KRT7 | 4.56 | 0.488 | 0.006 | BC002700 | Keratin 7 | |
203953_s_at | CLDN3 | −6.15 | −0.480 | 0.007 | BE791251 | Claudin 3 | |
35148_at | TJP3 | −2.87 | −0.478 | 0.008 | AC005954 | Tight junction protein 3 (zona occludens 3) |
Index: Affimetrix probe set ID, a unique identifier that can be used for GenBank accession numbers and consensus gene sequences.
‡ Slope: slope of the regression line between gene expression level and drug sensitivity.
r: Pearson's correlation coefficient. CDDP, cisplatin; CPT‐11, irinotecan hydrochloride; 5′‐DFUR, 5′‐deoxy‐5‐fluorouridine; S‐1, 1 M tegafur−0.4 M 5‐chloro‐2,4‐dihydroxypyridine−1 M potassium oxonate; UFT, 1 M tegafur−4 M uracil.